5 - Thyroid Flashcards
Causes of primary hypothyroidism
- Autoimmune thyroiditis (Hashimoto’s)
- Congenital
- Iodine deficiency
- Infiltrative disease (viral, bacterial)
- Drugs (lithium, amiodarone, interferons, tyrosine kinase inhibitors)
Describe hormone trends
- Primary hyperthyroidism = high T3 and T4, low TSH; primary = target organ (thyroid gland) is damaged
- Primary hypothyroidism = low T3 and T4, high TSH
- Secondary hyperthyroidism = high T3, T4, and TSH (dysfunction is at pituitary gland)
- Secondary hypothyroidism = low T3, T4, and TSH
Describe the function of thyroid hormones
- Affect the function of virtually every organ system
- Important for normal growth & dev’t in children
- Maintain metabolic stability in adults
Clinical manifestation (signs and sx) of thyroid disorders
- Hypothyroidism = weakness, fatigue, poor concentration/ memory, bradycardia, constipation, weight gain w/ poor appetite
- Hyperthyroidism = hyperactivity, irritability, dysphoria, tremor, tachycardia, diarrhea, goiter (enlarged thyroid gland -> swelling of neck)
Describe the role of TSH, T4, and T3
- TSH releases T4 & T3 (T4»_space;> T3)
- Majority protein bound = inactive
- Biologically most active = free T3
- T4 converted to T3 in periphery by 5’-deiodinase
Why isn’t T3 used as a drug? (levothyroxine = T4)
T4 is converted to T3 & we don’t want to lose the body’s ability to perform this conversion & T4 has longer t1/2 (almost like a pro-drug)
How do autoimmune thyroid diseases occur? What is the tx?
- Infiltration of thyroid w/ sensitized T lymphocytes (WBC)
- Acute inflammation of thyroid -> damage to gland -> release of T3 & T4
- Initially pt is hyperthyroid (high T3 & T4) but may become hypothyroid (in weeks to months)
- Chronic autoimmune thyroiditis (Hashimoto’s thyroiditis)
- Most common initial presentation = enlargement of thyroid gland (goiter)
- Tx = exogenous T4
Describe a goiter
- Generalized (diffuse) enlargement
- Caused by continuous stimulation by TSH
- Hashimoto’s – goiter eventually disappears due to progressive destruction of thyroid
Describe thyroid nodules
- Enlargement in 1 part of the gland (asymmetrical)
- Caused by benign/ malignant nodule
- Rarely associated w/ destruction of gland & hypothyroidism
Describe Graves’ disease
- Common cause of primary hyperthyroidism in adults & children
- Autoimmune, familial disposition
- Thyroid stimulating antibodies (TSAb) or thyroid stimulating immunoglobulins (TSI) mimic TSH -> autoimmune stimulation
- Continuous stimulation => high T3/T4; increase thyroid size
- Specific to Graves’ disease = opthalmopathy (pathogenesis unclear) & dermopathy (deposition of mucopolysaccharide; shin most common)
How are thyroid disorders classified?
- Hypothyroidism diagnosed when TSH is high & FT4 is less than population reference range
- Subclinical hypothyroidism
- Mild to moderate increased TSH, but total & FT4 normal
- If TSH very high (> 10) tx may be offered as these px may be at higher risk of CV complications
- TSH is the most reliable therapeutic endpoint for tx of hypothyroidism b/c most sensitive marker for monitoring
Lab monitoring for L-thyroxine tx
- FT4 is measured instead of FT3 b/c FT3 can be affected by other sources, so FT4 is more reliable
- After initiating or changing dose, re-measure FT4 & TSH 1 month later; want to measure levels in the morning
Factors that alter thyroxine & triiodothyronine binding in serum
- Increased TBG (T4-binding globulin) – estrogens, methadone, perphenazine, SERMs
- Decreased TBG – androgens, anabolic steroids, glucocorticoids
- Binding inhibitors – salicylates, furosemide, phenytoin, carbamazepine, NSAIDs, heparin
Consequences of untreated hypothyroidism
- Increased CV mortality
- Impaired intellectual function, depression, slowed speech, memory loss in elderly
- Anovulation, impaired fertility, increased rate of spontaneous abortion
- Myxedema coma (hypothermia, hypotension, hypoventilation, hyponatremia, bradycardia) – medical emergency
Dosing levothyroxine
- Healthy, young adults (< 50 y/o), children, older adults recently diagnosed w/ hypothyroidism, older adults recently treated for hyperthyroidism – initial 100-150 mcg/day titrated by 25 mcg q4-6weeks
- Adults > 50 y/o w/o cardiac disease, adults < 50 y/o w/ cardiac disease – 25-50 mcg/day titrated by 12.5-25 mcg q4-6weeks
- Adults > 50 y/o w/ cardiac disease – 12.5-25 mcg/day titrated by 12.5-25 mcg q4-6weeks
- Sx improvement in 2-3 weeks; maximal sx improvement in 4-6 weeks